Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AVLN | REPL |
|---|---|---|
| Price | $25.53 | $13.20 |
| Change today | ▲ 0.39% | ▼ 0.38% |
| Market cap | $1.13B | $1.24B |
| Return, 3 months | -11.7% | +18.8% |
| Return, year to date | – | +35.8% |
| Return, 1 year | – | +188.8% |
| P/E (TTM) | -11.0 | -4.2 |
| P/B | 2.8 | 11.8 |
| P/E percentile vs own 5y | 95th | 47th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -43.3% | +19.5% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -25.9% | -134.3% |
| Analyst target vs. price | +120.6% | +45.2% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 31 | 49 |
| 30-day volatility | 55.6% | 41.9% |
| Max drawdown, 1 year | -35.2% | -84.2% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
